Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

I C U Medical Inc (ICUI)

I C U Medical Inc (ICUI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
142.65 +4.22 (+3.05%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 142.65 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
135.55
Day High
144.41
Open 139.15
Previous Close 138.43 138.43
Volume 318,500 318,500
Avg Vol 343,275 343,275
Stochastic %K 62.44% 62.44%
Weighted Alpha +25.69 +25.69
5-Day Change +3.33 (+2.39%) +3.33 (+2.39%)
52-Week Range 93.36 - 196.26 93.36 - 196.26
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,497,634
  • Shares Outstanding, K 24,519
  • Annual Sales, $ 2,382 M
  • Annual Income, $ -117,690 K
  • EBIT $ 43 M
  • EBITDA $ 269 M
  • 60-Month Beta 0.86
  • Price/Sales 1.42
  • Price/Cash Flow 9.87
  • Price/Book 1.72

Options Overview Details

View History
  • Implied Volatility 70.24% ( -3.93%)
  • Historical Volatility 62.85%
  • IV Percentile 94%
  • IV Rank 85.45%
  • IV High 76.89% on 04/08/25
  • IV Low 31.21% on 06/12/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 1,541
  • Open Int (30-Day) 2,045

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.83
  • Number of Estimates 2
  • High Estimate 0.87
  • Low Estimate 0.79
  • Prior Year 0.60
  • Growth Rate Est. (year over year) +38.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
130.11 +9.64%
on 04/07/25
Period Open: 138.99
153.06 -6.80%
on 03/19/25
+3.66 (+2.63%)
since 03/11/25
3-Month
126.95 +12.37%
on 03/10/25
Period Open: 154.35
175.51 -18.72%
on 01/27/25
-11.70 (-7.58%)
since 01/10/25
52-Week
93.36 +52.80%
on 04/25/24
Period Open: 100.75
196.26 -27.32%
on 11/13/24
+41.90 (+41.59%)
since 04/11/24

Most Recent Stories

More News
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

MMSI : 92.04 (+0.55%)
PEN : 272.32 (+1.40%)
ICUI : 142.65 (+3.05%)
AORT : 23.37 (-0.68%)
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference

ICUI : 142.65 (+3.05%)
ICU Medical to Participate at the KeyBanc Healthcare Forum

ICUI : 142.65 (+3.05%)
3 Small-Cap Stocks Skating on Thin Ice

3 Small-Cap Stocks Skating on Thin Ice

RGEN : 122.86 (+6.66%)
ICUI : 142.65 (+3.05%)
DAY : 55.09 (+1.79%)
ICU Medical: Q4 Earnings Snapshot

ICU Medical: Q4 Earnings Snapshot

ICUI : 142.65 (+3.05%)
ICU Medical (NASDAQ:ICUI) Surprises With Q4 Sales

ICU Medical (NASDAQ:ICUI) Surprises With Q4 Sales

ICUI : 142.65 (+3.05%)
ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance

ICUI : 142.65 (+3.05%)
ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For

ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For

MMSI : 92.04 (+0.55%)
ICUI : 142.65 (+3.05%)
AORT : 23.37 (-0.68%)
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack

Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack

MMSI : 92.04 (+0.55%)
PEN : 272.32 (+1.40%)
ICUI : 142.65 (+3.05%)
AORT : 23.37 (-0.68%)
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

MMSI : 92.04 (+0.55%)
PEN : 272.32 (+1.40%)
ICUI : 142.65 (+3.05%)
AORT : 23.37 (-0.68%)
Vanda: Q1 Earnings Snapshot

Vanda: Q1 Earnings Snapshot

VNDA : 4.13 (+1.23%)
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

Future Pak wants Vanda, but Vanda doesn't want Future Pak.

VNDA : 4.13 (+1.23%)
Vanda: Q4 Earnings Snapshot

Vanda: Q4 Earnings Snapshot

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced its intention to file a petition for a writ of certiorari in its HETLIOZ®...

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals Announces Participation in the Jefferies Inaugural Biotech CNS/Neuro Summit

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies Inaugural Biotech...

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the H.C. Wainwright Global Investment...

VNDA : 4.13 (+1.23%)
Why Shares of Vanda Pharmaceuticals Are Dropping on Tuesday

The pharmaceutical company's stock hit another 52-week low.

VNDA : 4.13 (+1.23%)
Vanda: Q2 Earnings Snapshot

Vanda: Q2 Earnings Snapshot

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the second quarter ended June 30, 2023....

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals to Announce Second Quarter 2023 Financial Results on July 27, 2023

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2023 on Thursday, July 27,...

VNDA : 4.13 (+1.23%)
Vanda: Q1 Earnings Snapshot

Vanda: Q1 Earnings Snapshot

VNDA : 4.13 (+1.23%)
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

Future Pak wants Vanda, but Vanda doesn't want Future Pak.

VNDA : 4.13 (+1.23%)
Vanda: Q4 Earnings Snapshot

Vanda: Q4 Earnings Snapshot

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced its intention to file a petition for a writ of certiorari in its HETLIOZ®...

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals Announces Participation in the Jefferies Inaugural Biotech CNS/Neuro Summit

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Jefferies Inaugural Biotech...

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the H.C. Wainwright Global Investment...

VNDA : 4.13 (+1.23%)
Why Shares of Vanda Pharmaceuticals Are Dropping on Tuesday

The pharmaceutical company's stock hit another 52-week low.

VNDA : 4.13 (+1.23%)
Vanda: Q2 Earnings Snapshot

Vanda: Q2 Earnings Snapshot

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the second quarter ended June 30, 2023....

VNDA : 4.13 (+1.23%)
Vanda Pharmaceuticals to Announce Second Quarter 2023 Financial Results on July 27, 2023

/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2023 on Thursday, July 27,...

VNDA : 4.13 (+1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions,...

See More

Key Turning Points

3rd Resistance Point 155.06
2nd Resistance Point 149.73
1st Resistance Point 146.19
Last Price 142.65
1st Support Level 137.33
2nd Support Level 132.00
3rd Support Level 128.46

See More

52-Week High 196.26
Fibonacci 61.8% 156.95
Fibonacci 50% 144.81
Last Price 142.65
Fibonacci 38.2% 132.66
52-Week Low 93.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar